Deepak Srivastava, M.D., is President of the Gladstone Institutes, an independent nonprofit life science research institute with a mission of driving a new era of discovery in disease-oriented science. Dr. Srivastava directs the Roddenberry Stem Cell Center at Gladstone, and is a Professor of Pediatrics and Biochemistry & Biophysics at the University of California, San Francisco (UCSF) Medical Center.

Dr. Srivastava received his B.S. from Rice University, M.D. from University of Texas, trained in pediatrics at UCSF, and in pediatric cardiology at Harvard Medical School.

Dr. Srivastava’s laboratory discovered the genetic basis for several human cardiac birth defects and revealed complex gene networks that regulate stem cells to adopt a cardiac cell fate and subsequently fashion a functioning heart. He has leveraged this knowledge to convert scar-forming cells in the heart directly into muscle-like cells to regenerate damaged hearts.  He has co-founded two biotech companies to take such discoveries to clinical trials, and is the immediate past-president of the International Society for Stem Cell Research. Dr. Srivastava is a member of the American Academy of Arts and Sciences and the National Academy of Medicine.